TY - JOUR
T1 - Helicobacter pylori seropositivity and coronary heart disease incidence
AU - Folsom, Aaron R.
AU - Nieto, F. Javier
AU - Sorlie, Paul
AU - Chambless, Lloyd E.
AU - Graham, David Y.
PY - 1998/9/1
Y1 - 1998/9/1
N2 - Background - Several epidemiological and clinical reports have suggested seropositivity for Helicobacter pylori may be a risk factor for coronary heart disease. However, there has been no prospective study of this association involving an ethnically diverse sample of middle-aged men and women. Methods and Results - Using a prospective, case-cohort design, we determined H pylori seropositivity in relation to coronary heart disease incidence over a median follow-up period of 3.3 years among middle-aged men and women. There were 217 incident coronary heart disease cases and a cohort sample of 498. We determined H pylori antibody status by measuring IgG antibody to the high-molecular-weight cell-associated proteins of H pylori using a sensitive and specific ELISA. The prevalence of H pylori seropositivity was higher in blacks than whites, in those with less than high school education, in those with lower plasma pyridoxal 5'-phosphate and higher homocyst(e)ine concentrations, in those who did not use vitamin supplements, in those with higher fibrinogen levels, and in those seropositive for cytomegalovirus and herpes simplex type I (all P<0.05). The age-, sex-, race-, and field center-adjusted hazard ratio of coronary heart disease for H pylori seropositivity was 1.03 (95% CI=0.68 to 1.57). After adjustment for other risk factors, including fibrinogen, cytomegalovirus seropositivity, and herpes simplex type I seropositivity, the hazard ratio was 0.85 (95% CI=0.43 to 1.69). H pylori seropositivity also was not associated with increased mean intima, media thickness of the carotid artery, a measure of subclinical atherosclerosis. Conclusions - H pylori infection is probably not an important contributor to clinical coronary heart disease events.
AB - Background - Several epidemiological and clinical reports have suggested seropositivity for Helicobacter pylori may be a risk factor for coronary heart disease. However, there has been no prospective study of this association involving an ethnically diverse sample of middle-aged men and women. Methods and Results - Using a prospective, case-cohort design, we determined H pylori seropositivity in relation to coronary heart disease incidence over a median follow-up period of 3.3 years among middle-aged men and women. There were 217 incident coronary heart disease cases and a cohort sample of 498. We determined H pylori antibody status by measuring IgG antibody to the high-molecular-weight cell-associated proteins of H pylori using a sensitive and specific ELISA. The prevalence of H pylori seropositivity was higher in blacks than whites, in those with less than high school education, in those with lower plasma pyridoxal 5'-phosphate and higher homocyst(e)ine concentrations, in those who did not use vitamin supplements, in those with higher fibrinogen levels, and in those seropositive for cytomegalovirus and herpes simplex type I (all P<0.05). The age-, sex-, race-, and field center-adjusted hazard ratio of coronary heart disease for H pylori seropositivity was 1.03 (95% CI=0.68 to 1.57). After adjustment for other risk factors, including fibrinogen, cytomegalovirus seropositivity, and herpes simplex type I seropositivity, the hazard ratio was 0.85 (95% CI=0.43 to 1.69). H pylori seropositivity also was not associated with increased mean intima, media thickness of the carotid artery, a measure of subclinical atherosclerosis. Conclusions - H pylori infection is probably not an important contributor to clinical coronary heart disease events.
KW - Coronary disease
KW - Epidemiology
KW - Helicobacter pylori
UR - http://www.scopus.com/inward/record.url?scp=0344269334&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344269334&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.98.9.845
DO - 10.1161/01.CIR.98.9.845
M3 - Article
C2 - 9738638
AN - SCOPUS:0344269334
SN - 0009-7322
VL - 98
SP - 845
EP - 850
JO - Circulation
JF - Circulation
IS - 9
ER -